Topics:
Pediatric Oncology • Medical Oncology • Thrombosis • Hematology • Pediatric Hematology • Benign Hematology • Hemostasis/Thrombosis
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
Would you consider low dose indefinite anticoagulation in any scenario? Any difference in approach between hematological malignancy and solid tumors?
Answer from: Medical Oncologist at Academic Institution
Your approach to incidental thromboembolism found on the workup of malignancy should be similar to any evaluation of a thrombosis. It should be a structured approach with the following questions evaluated before deciding on long-term or short-term anticoagulation. First, one should determine the loc...
Sign in or Register to read more